bpc-157 coa of BPC 157 acetate | Certificate of Analysis BPC-157 (Body Protection Compound-157) |

A phase 2b clinical trial was completed in Australia on 300 obese individuals

doi: 10.1136/gutjnl-2021-325177 38 SuQLiuQLauRIZhangJXuZYeohYKet al

BPC-157 is also known as a stable gastric pentadecapeptide primarily because it is stable in human gastric juice, can cause an anabolic healing effect in both the upper and lower GI tract, has an antiulcer effect, and produces a therapeutic effect on inflammatory bowel disease (IBD)all again surprisingly free of side effects

BPC 157 has beneficial effects on inflammation, hemorrhage, and edema after traumatic brain injury [33], various severe encephalopathies (which follow gastrointestinal and/or liver lesions), NSAID overdose [34,35,36,37], or insulin overdose seizures [38] and on severe muscle weakness after exposure to the specific neurotoxin cuprizone in a rat multiple sclerosis model [39] or magnesium overdose [40]

3T3-L1 pre-adipocytes cells were cultured with standard culture media (DMEM, 4.5 g/L glucose, L-glutamine, sodium pyruvate, 10% FBS, 1% antibiotic-antimycotic solution) and grown for 48 h before initiating differentiation using the manufacturer's suggested protocol and modified from previous published work